- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 19-02-2026: Press Release
19-02-2026 | 09:50 am
19-02-2026 | 09:50 am
Zydus launched Anyra™, India's first indigenously developed Aflibercept 2 mg biosimilar, bolstering ophthalmic care. This move, following an agreement with Regeneron and Bayer, targets large patient populations with conditions like wet AMD and DME, enhancing Zydus's biosimilar market position.
No comments yet. Be the first to comment!